PMID: 16613771Apr 15, 2006Paper

Antithrombotics (Antithrombin therapy)

Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology
Serdar Payzin

Abstract

Thrombus on the atherosclerotic plaque is mainly responsible for acute coronary syndromes. Antithrombin therapy continues to be the mainstay of the therapy defeating thrombus. Up-to-date antithrombin therapy consists of vitamin K antagonists, unfractionated and low molecular heparins, direct thrombin inhibitors and selective inhibitors of factor Xa. Today, none of these drugs is effective enough in every aspect. The need for new antithrombin drugs, as well as the need for new antiplatelet drugs which can be safely and effectively used together with other antithrombin drugs, persists.

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

PharmacoEconomics
Jaime Latour-Pérez, Eva de-Miguel-Balsa
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
Elena I SinauridzeFazoil I Ataullakhanov
Australian and New Zealand Journal of Medicine
P A Tideman
© 2022 Meta ULC. All rights reserved